Flourishing Cannabis Companies Seek to Fill Corporate Roles
Zynerba Pharmaceuticals, Inc. (ZYNE)
Last zynerba pharmaceuticals, inc. earnings: 3/10 06:50 am
Check Earnings Report
US:NASDAQ Investor Relations:
ir.zynerba.com
Company Research
Source: PR Newswire
NEW YORK, May 29, 2019 /PRNewswire/ -- As the cannabis industry begins to heat up, companies are aggressively seeking employees to fill positions. Decades ago, the cannabis plant was being reintroduced into states such as California, Oregon, Alaska, and Washington. Since then, California and nine more states and the District of Columbia have legalized recreational cannabis use. Moreover, countries across the world have begun to decriminalize or legalize cannabis on some level as, notably, Canada became the second nation ever to legalize cannabis entirely back in late 2018. The rapid expansion and development of the industry further highlight the profound impact cannabis is having around the world. Furthermore, ZipRecruiter reported that cannabis jobs openings increased by 445%, outpacing even the technology (254%) and healthcare (70%) industries. Primarily, positions such as brand ambassadors, sales associates, product managers, and delivery drivers are firmly in demand, according to
Show less
Read more
Impact Snapshot
Event Time:
ZYNE
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ZYNE alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ZYNE alerts
High impacting Zynerba Pharmaceuticals, Inc. news events
Weekly update
A roundup of the hottest topics
ZYNE
News
- Zynerba Pharmaceuticals, Inc. (NASDAQ: ZYNE) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.MarketBeat
- Zynerba Pharmaceuticals Announces Podium and Poster Presentations at the American Society of Clinical Psychopharmacology Annual MeetingGlobeNewswire
- Zynerba Pharmaceuticals, Inc. (NASDAQ: ZYNE) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.MarketBeat
- Zynerba Pharmaceuticals Reports First Quarter 2023 Financial Results and Operational HighlightsGlobeNewswire
- Zynerba Pharmaceuticals, Inc. (NASDAQ: ZYNE) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.MarketBeat
ZYNE
Earnings
- 8/10/22 - Miss
ZYNE
Analyst Actions
- 4/5/23 - Cantor Fitzgerald
ZYNE
Sec Filings
- 5/15/23 - Form 10-Q
- 5/15/23 - Form 8-K
- 5/15/23 - Form DEFA14A
- ZYNE's page on the SEC website